Available online on 15.10.2025 at http://jddtonline.info

Journal of Drug Delivery and Therapeutics

Open Access to Pharmaceutical and Medical Research

Copyright  © 2025 The   Author(s): This is an open-access article distributed under the terms of the CC BY-NC 4.0 which permits unrestricted use, distribution, and reproduction in any medium for non-commercial use provided the original author and source are credited

Open Access Full Text Article                                                                                 Review Article

AI and Machine Learning in Pharmaceutical Manufacturing: Revolutionizing Process Optimization

Ashish Gorle *, Shruti Pawar, Arak Dipali, Hritik Nimbarthe, Chaudhary Leena

Dept. Pharmaceutical Technology, R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur, Tal. Shirpur, Dist. Dhule, Maharashtra, India, 425 405. 

 

 

Introduction 

AI refers to many technologies, including machine learning (ML), deep learning, natural language processing, and robotics. This allows the system to mimic human intelligence and perform tasks that are assumed to require human intervention. The concept of AI was established in 1956 during a meeting by Marvin Minsky and John McCarthy ^1,2. AI includes various methods such as Natural Language Processing ³, Computer Vision ⁴ and Robotics ⁵. 

For years, pharmaceutical manufacturers have been looking for paths to improve efficiency, reduce costs, maintain product quality, and simultaneously meet regulatory standards. The pharmaceutical industry recognizes the potential of AI and ML to address key challenges related to cost, efficiency, and product quality. The introduction of artificial intelligence (AI) and machine learning (ML) promises to overcome, analyse and optimize the capabilities of the dynamics of production processes.

In the past, drug production has been a manual and time-consuming process that relies on human intervention for process monitoring, product testing, and decision-making. However, the rapid development of AI and ML in recent years has enabled manufacturers to automate many aspects of their production cycle, from process control to quality assurance. Today, these technologies are an important part of the digital transformation of drug production and can form the entire value chain. Over the past five years, the use of artificial intelligence in the pharmaceutical and biotechnology industry has redefine how scientists develop new drugs and develop attack diseases ⁶. In particular, it focuses on key applications such as forecasting, quality control, and overall process optimization in drug production. 

1. Historical Evolution and Goals of AI and ML in Pharmaceutical Manufacturing:

History:

Allen Newell and Herbert A. Simon. Developed as a logic theorist was born in 1956 Dartmouth College had organized the famous conference ⁷.  Sales from the AI market are projected to have increased by up to 10 times between 2017 and 2022. The natural language processing market has several applications, including text and language recognition prediction and language recognition to achieve a 28.5% growth in 2017. Worldwide revenue from big data and business analytics was US$ 122 billion in the year 2015 and it is being expected that the figures will rise to more than US$ 200 billion by the year 2020 ⁸. Artificial intelligence has rocky stories dating back to the 1950s. It was long considered a field for dreamers, but it began to change in 1997 when IBM's deep blue computer was able to defeat chess master Garry Kasparov. By 2011, IBMs new Watson supercomputer was able to win the US$1m prize in the US game-show Jeopardy. Since then, Watson has expanded its healthcare and drug discovery in 2016, including a partnership with Pfizer to accelerate drug discovery in immune disorders. In December 2016, IBM introduced it in collaboration with Pfizer IBM Watson, a report from the Cloud-based Medical Institute, to help researchers identify relationships between different data records through dynamic visualization ⁹.

1.1 Historical Development of AI and ML in Pharmaceutical Manufacturing

AI and ML are known to be the first use of these technologies in the pharmaceutical industry in the mid-20th century ever since the advent of the first computer models and algorithms that were used for data analysis and decision making. However, AI in the pharmaceutical sector really took off due to the advent of powerful computing systems and the development of statistical

learning models in the 1990s. As for the earliest systems, they were mostly the solution for drug discovery, safety assessments, and clinical trials through data analysis. Nonetheless, ML in the early 2000s the technology advanced and ere systems that were more complicated, could learn from data and improve predictions without programming came to exist. AI and ML were used in pharmaceutical manufacturing, depending on the ability to optimize, automate, and complete real-time data analysis. 

In recent years, discoveries in deep learning, big data analytics and sensor technologies have further speeded up the AI and ML arrival. From the end of last century until the present day, these new developments have become a regular part of pharmaceutical manufacturing and are currently utilized in areas like process development, predictive maintenance, quality control, and regulatory compliance.

1.2 Growth of AI and ML Technologies in the Pharmaceutical Sector

The largest advances in AI and ML were made over the last two decades because of data analysis, sensors, cloud computing, which gave the chance to make these technologies more applicable and available in the real-world contexts. Right now, AI and ML are applied in the whole production cycle of pharmaceuticals which begins, e.g. with the procurement of raw material and ends with the distribution of the final product. 

These technologies make possible the start of production and production planning on time, prognostics, and process improvement that were previously undoable or not efficiently done via traditional methods. As companies work towards digital transformation in the pharmaceutical industry, AI and ML are becoming more and more important tools that help increasing productivity and maintaining high-quality standards.

1.3 Goals of AI and ML in Pharmaceutical Manufacturing

The primary goals of implementing AI and ML in pharmaceutical manufacturing are to optimize processes, improve product quality, reduce costs, and ensure regulatory compliance. More specifically, AI and ML aim to:

Enhance process efficiency: 

AI and ML algorithms are able to optimize various production stages so that they do not cause the creation of waste in the process and thus the least amount of time is used. This process can begin from the onset of a project (in the case of formulation development) and run through to the end. AI and ML in production can photo scanning to ensure that the correct material is used for a production product. The AI and ML system would communicate with the tray loader. 

Improve product quality:

The quality of the products nowadays can be easily controlled because of artificial intelligence which automatically, in real time, keeps track of production, thus ensures that every piece produced meets the required specifications and a minimum of defects or inconsistencies are made.

Predict and prevent equipment failure: 

The AI-driven predictive maintenance can effectively predict the equipment failure beforehand thus helping in saving costs and due to maintenance and reduced downtime.

Streamline regulatory compliance: 

Good Manufacturing Practices (GMP) are enforced to ensure that regulations are met in the production process. However, AI can assist with automating compliance documentation and real-time monitoring. 

2. Applications of AI and Machine Learning in Pharmaceutical Manufacturing:

2.1 Predictive Maintenance 

It is a standout application in the pharmaceutical industry where AI and ML are put to use. In the traditional systems of maintenance, sometimes schedule-based or instruments respond only for equipment failure. In AI-based predictive maintenance systems, however, the use of machine learning algorithms to monitor equipment performance in real time, predict future failures and are based on the data from sensors and the findings of the historical records are common. 

For example, research conducted by Zhao et al. in 2019 ^[10] showed that an AI-driven predictive maintenance system could lessen the unplanned downtimes in tablet production lines by 30%. A system by ambiguity analytics and adjacent standardized solutions, through analysing data about vibration, temperature changes, and operational patterns was able to forewarn the system breakdowns before they stopped the production process.

 

 

 

Figure 1: Overview Of Pharmaceutical Manufacturing Process

 

 

2.2 Quality Control and Assurance

AI and ML technologies are integral in assuring the pharmaceutical products in good quality. Traditional quality methods are manual inspection, statistical sampling, and laboratory tests, and are time-consuming, error-prone, and subjective. AI and ML can accelerate and improve quality control by offering very near real-time quality and high-precision inspection as regards conditions of manufacturing and attributes of the products.

Machine Vision: AI-driven machine vision systems are widely used for visual inspections to detect defects in packaging, labelling, and product appearance. These systems can identify even the smallest deviations from product specifications, improving accuracy and consistency in quality control.

Predictive Quality Control: ML algorithms predict quality-related problems from the data they receive coming from the sensors, conditions within the environment, and parameters of production. Being able to predict problems allows manufacturers to solve them before they result in defective products, therefore all the products made would be adhering to regulatory authority standards set

For example, in the study done by Kong et al. (2021), AI systems were used for quality control in tablet manufacturing, defect detection such as cracks or missing components during real-time inspection, enhanced accuracy, speed up inspection, and cutting production waste ¹¹.

2.3 Process Optimization

AI and ML technologies have the capability of being able to optimize various stages of the drugs manufacturing process starting from the selection of the raw material and going all the way to the final product packaging. In this sense, these technologies, by providing detailed insights, help optimize, reduce waste, and improve yield by varying the parameters like heat, pressure, and the speed mixing.

Speculations and Ratios: AI-based models help simulate the entire production process in industries and are able to identify areas of inefficiency and provide appropriate solutions. By this means, these models assist the manufacturers in not only being capable of effectively producing their pharmaceuticals and in shortening the times required for the development of new ones but also in the ability to reduce the costs of the company in the long run.

Example: A Vishwakarma et al. (2020-2017) experiment, the researchers used AI-based process simulations to size the solvent evaporation in the active pharmaceutical ingredient (API) production process. The newly developed optimization chart led the company to produce higher yields and less waste, thus, the efficiency of the production process was the result of this development ¹².             

2.4 Supply Chain Optimization and Inventory Management

Supply chain efficiency is the most important factor for the pharmaceutical industry, where the timely delivery of raw materials and finished products is a must. As a result, we have implemented AI and ML technologies to improve forecasting accuracy, inventory management, and distribution logistics, that is, that resources are utilized in an optimized manner throughout the entire supply chain.

Demand Forecasting: AI algorithms are sufficient and can analyse past sales data, market trends, and other external factors to predict future demand more accurately. This action reduces inventory turnaround times and stockouts, and the overall supply chain is efficient.

Optimization Algorithms: Thanks to ML models, it is possible to intelligently schedule production by taking the following dimensions into account: inventory, production capacity, and delivery deadlines. This warrants demand-production alignment, which in turn decreases bottlenecks as well as ramps supply chain flexibility.

Example: Nguyen et al. (2021) leveraged AI to supply chain optimization in pharmaceutical manufacturing, thereby raising inventory turnover and equating market demand prediction and production schedule alteration ¹³.

2.5 Regulatory Compliance and Data Integrity

The area where compliance is a primary and most fundamental notion to stick with the set trends in pharmaceuticals being produced is regulatory compliance. Companies are expected to conform to strict regulations, such as Good Manufacturing Practices (GMP) and 21 CFR Part 11, in the United States, etc. But this is where AI and ML can come in and solve this problem by automating compliance-related tasks such as accurate data capture, real-time monitoring as well as consistent documentation.

Data Integrity: AI is effective in that it is a system that can automatically generate compliance documents and store them hence resulting in the maintenance of the data integrity as well as adequate documentation of all production steps. The problem of human error is diminished, and the audit is a far greater chance of success.

Compliance Monitoring: Thirdly, technology can in real-time supervise the production process to ensure that the standard operating procedures are followed, alerting the operators in case of deviation or potential non-compliance issues that might otherwise become serious.

2.6 Drug Formulation and Development

AI and ML are gaining ground in the development and formulation of drugs. AI algorithms, by sifting through large data sets, can find the right combinations of ingredients as well as the desirable processing conditions; thus, leveling the playing field with the traditional time-consuming and expensive trial-and-error methods. This, consequently, renders significantly shorter development cycles and, besides, enhances the cost-effectiveness of production exponentially.

Example: To illustrate, in Patel et al.'s research in 2022 on solid oral dosage forms, machine learning models worked out the optimal formulation parameters that led to overcoming the difficult and rather complicated stages easily ¹⁴. 

3. Benefits of AI and ML in Pharmaceutical Manufacturing:

3.1. Enhanced Process Optimization

The most advanced technology called AI and ML algorithms which are used in analysis of abundant information the best production conditions can be detected. The following are as a result of this:

• Products made at increased efficiency;
• Variety in drug's no longer an issue;
• Immediate modification due to imbalance in ongoing operations; and so on ¹⁵. 

3.2. Improved Quality Control

An innovative platform that AI supports assists Quality Assurance departments in: 

• Checking for product and packaging errors using a camera;
• Tracking some of the production parameters temperature, pH, and pressure in real-time with no breaks;
• Warn the release of a product to be down the alley;¹⁶.

3.3 Predictive Maintenance

Predicative analytics prevent equipment failures by: 

• Studying sensor data towards identifying predictions about any potential breakdown. 
• Proactive scheduling of maintenance to have a reduced downgraded time. 
• Extending the lifespan of machinery ¹⁷. 

3.4 Supply Chain Optimization

AI helps efficiency in supply chain management by:

• Forecasting the demand to avoid overproduction or shortages. 
• Carrying out optimized inventory control. 
• Real-time tracking of shipments and raw materials ^18,19.  

3.5 Eased and Speedy Drug Development

AI and machine learning have made drug development much easier and faster in the following ways: 

• Finally locating potential drug candidates using data-driven simulations. 
• Predicting drug interactions, along with patient-specific responses. 
• They are working towards making the scalability of production from lab to factory larger ²⁰. 

3.6. Regulatory Compliance

Automated monitoring systems assure to stick to a set of rules prescribed by:

• Highlighting the non-conformity in the document and the whole process.
• Keeping a track of all stages of the audit in a transparent manner.
• Giving the company good credit by adhering to the set regulations and thereby reducing the risk of penalties ²¹. 

3.7. Real-Time Monitoring and Decision-Making

AI & ML are the systems of the real-time monitoring of the production processes, which are flexible so that changes in the processes can be made in situ. This process, in turn, enables nimbler and not to mention in-time response to the changing state of the production field.

3.8. Cost Reduction

Pharma companies attain the lessening of downtimes through predictive maintenance, lessening of defects through proper quality control, and the optimization of production processes thanks to AI and ML, which lead to the significant cost reduction. Pharmaceutical manufacturers can decrease operational costs by being more efficient and maintaining a certain level of quality and consistency of their production. 

4. Challenges and Limitations:

4.1 Data Quality and Availability

AI and ML systems operate based on abundant amounts of good-quality data to perform well. Poor quality, incomplete, or inconsistent data will result in poor-quality predictions and decisions. A critical requirement for AI-based systems' success is having good quality and comprehensive data available.

4.2 Integration with Legacy Systems

It is challenging to integrate AI and ML technologies into existing manufacturing assets and legacy systems. It entails substantial investment in the modernization of hardware, software, and IT infrastructure and in training personnel to operate with new technologies.

4.3 Regulatory and Ethical concern 

As AI becomes increasingly integrated into decision-making, there are concerns of regulatory and ethical nature. Transparency, accountability, and fairness in AI algorithms must be ensured to maintain trust and ensure compliance with industry standards. 

5. Future Prospects of AI and ML in Pharmaceutical Manufacturing:

5.1 The Role of Industry 4.0

Artificial Intelligence and Machine Learning are the key components of Industry 4.0, which mainly deals with the integration of digital technologies-Internet of Things, big data analytics, and automation-in manufacturing. The future will welcome further process optimization through the convergence of AI, IoT, and automation; this will allow for real-time monitoring, predictive maintenance, and self-optimizing production lines. 

5.2 Advancements in AI and ML Models

As competitiveness and efficiency increase over time, AI and ML will grow into even greater plant pharmaceuticals production challengers. For instance, deep learning algorithms may improve the quality of predictive models concerning drug formulation, process, and quality control will be augmented by real-time high-volume data processing capability of AI. AI will help decision-making largely and enhance the responsiveness of the pharmaceutical manufacturing process.

5.3 Personalized Medicine and AI

AI and ML will also be at the forefront in the creation of personalized medicine. Through genetic data analysis, patient profiles, and clinical outcomes, AI is capable of developing bespoke pharmaceutical products tailored to individual patient needs. The personalized method of drug production can transform the sector and enhance patient outcomes. 

6. Conclusion:

AI and ML are revolutionizing pharmaceutical manufacturing by providing novel solutions for process optimization, quality management, predictive maintenance, and regulatory compliance. These technologies enhance efficiency, save costs, increase product quality, and facilitate real-time decision-making. Although there exist challenges of data quality, system integration, and regulatory issues, the future of AI and ML in pharmaceutical manufacturing is full of promise. Ongoing development of AI algorithms, machine learning models, and manufacturing infrastructure will continue to optimize the industry, leading to more efficient and sustainable production methods. 

Acknowledgements: The authors are thankful to the Management of R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur for providing the necessary facilities, support and encouragement.

Conflict of Interest: None

References

1. Jiang J, Xyangyu Ma, Ouyang D, Robort O. Williams III, Emerging artificial intelligence (AI) technologies are used in the development of solid dosage forms. Pharmaceutics. 2022; 14(11), 2257 https://doi.org/10.3390/pharmaceutics14112257 PMid:36365076 PMCid:PMC9694557

2. Sheikh H, Prins C, Schrijvers E, Artificial Intelligence: Definition and Background. In: Mission AI. Research for Policy. Publisher Springer, Cham, 2023, https://doi.org/10.1007/978-3-031-21448-6_2 https://doi.org/10.1007/978-3-031-21448-6_2

3. Chen Y, Wang H, Yu K, Zhou R, Artificial Intelligence Methods in Natural Language Processing: A Comprehensive Review, Highlights in Science Engineering and Technology, 2024; 85:545-550 https://doi.org/10.54097/vfwgas09

4. Patel V, Shah M, Artificial intelligence and machine learning in drug discovery and development. Intelligent Medicine. 2022; 2(3):134-140 https://doi.org/10.1016/j.imed.2021.10.001

5. Blanco-Gonzalez A, Alfonso Cabezon A, Seco-Gonzalez A, Conde-Torres, Antelo-Riveiro P, Angel Pineiro A, Rebeca Garcia-Fandino R, The Role of AI in Drug Discovery: Challenges, Opportunities, and Strategies, Pharmaceuticals MDPI, 2023; 16(6):891 https://doi.org/10.3390/ph16060891 PMid:37375838 PMCid:PMC10302890

6. Paul D, Sanap G, Shenoy S, Kalyane D, Kalia K, Tekade RK, Artificial intelligence in drug discovery and development, Drug Discovery. Today, 2021; 26:80-93 https://doi.org/10.1016/j.drudis.2020.10.010 PMid:33099022 PMCid:PMC7577280

7. Xu Y, Liu X, Cao X, Huang C, Liu E, Qian S, Liu X, Wu Y, Dong F, Qiu CW, Artificial intelligence: A powerful paradigm for scientific research. Innovation. 2021; 2:100179. https://doi.org/10.1016/j.xinn.2021.100179 PMid:34877560 PMCid:PMC8633405

8. Wirtz B.W. Artificial intelligence and the public sector-applications and challenges, International Journal of Public Administration, 2019; 42:596-615. https://doi.org/10.1080/01900692.2018.1498103

9. Mak K.-K., Pichika M.R. Artificial intelligence in drug development: present status and future prospects, Drug Discovery Today, 2019; 24:773-780 https://doi.org/10.1016/j.drudis.2018.11.014 PMid:30472429

10. Singh R, Arya P, Dubey SH, Artificial Intelligence in Pharmaceutics: Revolutionizing Drug Formulation and Optimization, Journal of Drug Discovery and Health Sciences, 2024; 1(03):138-145 https://doi.org/10.21590/jddhs.01.03.03

11. Saha GC, Eni LN, Saha H, Parida PK, Rathinavelu R, Jain SK, Haldar B, Artificial Intelligence in Pharmaceutical Manufacturing: Enhancing Quality Control and Decision Making, Rivista Italiana di Filosofia Analitica Junior, 2023; 14(2):116-126

12. Khalid S, Optimization of Pharmaceutical Processes Using Artificial Intelligence, 2025; 5(1):1134-44 https://doi.org/10.18535/cmhrj.v5i1.447

13. Gupta R, Srivastava D, Sahu M, Tiwari S, Ambasta RK, Kumar P, Molecular Diversity, 2021; 25(3):1315-1360 https://doi.org/10.1007/s11030-021-10217-3 PMid:33844136 PMCid:PMC8040371

14. Ali KA, Mohin S, Mondal P, Goswami S, Ghosh S, Choudhuri S. Influence of artificial intelligence in modern pharmaceutical formulation and drug development, Future Journal of Pharmaceutical Sciences, 2024;10(1):53 https://doi.org/10.1186/s43094-024-00625-1

15. Zhu H. Big data and artificial intelligence modelling for drug discovery, The Annual Review of Pharmacology and Toxicology, 2020; 60:573-589 https://doi.org/10.1146/annurev-pharmtox-010919-023324 PMid:31518513 PMCid:PMC7010403

16. Mundhra S, Kadiri SK, Tiwari P, Harnessing AI and Machine Learning in Pharmaceutical Quality Assurance, Journal of Pharmaceutical Quality Assurance and Quality Control, 2024; 6(1):19-29

17. Curate B, AI: optimizing personalized medicine with artificial intelligence, SLAS Technology, 2020; 25:95-105 https://doi.org/10.1177/2472630319890316 PMid:31771394

18. Rishi R Gupta, Application of Artificial Intelligence and Machine Learning in Drug Discovery, Methods in Molecular Biology, 2022; 2390:113-124 https://doi.org/10.1007/978-1-0716-1787-8_4 PMid:34731466

19. Chan HS, Advancing drug discovery via artificial intelligence, Trends in Pharmacological Sciences 2019; 40(8):592-604 https://doi.org/10.1016/j.tips.2019.06.004 PMid:31320117

20. Duch W, Artificial intelligence approaches for rational drug design and discovery, Current Pharmaceutical Design, 2007; 13:1497-1508 https://doi.org/10.2174/138161207780765954 PMid:17504169

21. Paul D, Sanap G, Shenoy S, Kalyane D, Kalia K, Tekade R, Artificial intelligence in drug discovery and development, Drug Discovery Today, 2020; 21;26(1):80-93 https://doi.org/10.1016/j.drudis.2020.10.010 PMid:33099022 PMCid:PMC7577280